PRPH Past Earnings image   This PRPH past earnings page last updated 11/11/2022
PRPH Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.060
Q2 20228/11/20220.400
Q1 20225/13/20220.680
Q4 20213/30/20220.680
Q3 202111/12/2021-0.260
Q2 20218/13/2021-0.090
Q1 20215/13/20210.270
Q4 20203/31/2021-0.250
Q3 202011/16/2020-0.050
Q2 20208/11/20200.010
Q1 20205/12/2020-0.070
Q4 20193/25/2020-0.040
Q3 201911/12/2019-0.040
Q2 20198/12/2019-0.110
Q1 20195/14/2019-0.090
Q4 20183/26/2019-0.04
Q3 201811/14/2018-0.09
Q2 20188/20/2018-0.02
Q1 20185/15/20180
Q4 20173/21/20180.04
Q3 201711/13/2017-0.05
Q2 20178/11/2017-0.09
Q1 20175/15/20170.95
Q4 20162/27/2017-0.04
Q3 201611/14/20160.01
Q2 20168/9/2016-0.06
Q1 20165/10/2016-0.08
Q4 20153/29/2016-0.07
Q3 201511/12/20150.04
Q2 20158/12/2015-0.1
Q1 20155/13/2015-0.09
Q4 20143/25/2015-0.05
Q3 201411/17/20140.02
Q2 20148/12/2014-0.19
Q1 20145/12/2014-0.05
Q4 20133/27/20140.04
Q3 201311/13/20130.08
Q2 20138/13/2013-0.11
Q1 20135/6/20130.02
Q3 201211/14/20120.07
PRPH Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.02B
Q2 20228/11/20220.03B
Q1 20225/13/20220.05B
Q4 20213/30/20220.05B
Q3 202111/12/20210.01B
Q2 20218/13/20210.01B
Q1 20215/13/20210.02B
Q4 20203/31/20210.01B
Q3 202011/16/20200.00B
Q2 20208/11/20200.00B
Q1 20205/12/20200.00B
Q4 20193/25/20200.00B
Q3 201911/12/20190.00B
Q2 20198/12/20190.00B
Q1 20195/14/20190.00B
Q4 20183/26/20194.09M
Q3 201811/14/20182.44M
Q2 20188/20/20183.19M
Q1 20185/15/20183.41M
Q4 20173/21/20184.15M
Q3 201711/13/20173.04M
Q2 20178/11/20171.91M
Q1 20175/15/2017771000
Q4 20162/27/20177.61M
Q3 201611/14/20165.19M
Q2 20168/9/20162.85M
Q1 20165/10/20165.37M
Q4 20153/29/20168.16M
Q3 201511/12/20154.39M
Q2 20158/12/20152.19M
Q1 20155/13/20155.86M
Q4 20143/25/20159.00M
Q3 201411/17/20145.13M
Q2 20148/12/20141.80M
Q1 20145/12/20146.17M
Q4 20133/27/20149.08M
Q3 201311/13/20130.01B
Q2 20138/13/20130.00B
Q1 20135/6/20130.01B
Q3 201211/14/20125.42M
Quotes delayed 20 minutes

Email EnvelopeFree PRPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ProPhase Labs (PRPH) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PRPO Past Earnings
PRTA Past Earnings
PRTK Past Earnings
PRVA Past Earnings
PRVB Past Earnings
PSNL Past Earnings
PSTV Past Earnings
PSTX Past Earnings
PTCT Past Earnings
PTE Past Earnings

PRPH Past Earnings Q&A

What was the best and worst PRPH past earnings results?
For ProPhase Labs, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PRPH past earnings result in our data set was 0.95/share posted in Q1 2017, while the lowest was in Q3 2021 when PRPH posted -0.260/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when PRPH reported 0.05B in revenue, while the quarter with the lowest revenue in our data set was Q1 2017 at 771000 of revenue.

  Suggested answer: There are 40 PRPH past earnings results in our data set.

On this page we presented the PRPH past earnings date information for ProPhase Labs. Reviewing that PRPH Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2017, when PRPH posted gaap of 0.95/share. Meanwhile the lowest PRPH past earnings result was in Q3 2021, when PRPH posted gaap of -0.260/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when PRPH reported 0.05B in revenue, while the smallest revenue quarter was Q1 2017 when PRPH reported 771000 in revenue.

Any self directed investor doing their due diligence on PRPH or any other given stock can benefit from researching all of the ProPhase Labs past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate ProPhase Labs past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PRPH. Thanks for visiting, and the next time you need to research PRPH past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of UE, IVV Average Annual Return, Top Ten Hedge Funds Holding RCKB.

 

PRPH Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.